Teva- Pharmaceutical Industries Ltd

NYSE: TEVA
$17.12
-$0.26 (-1.5%)
Closing Price on November 12, 2024

TEVA Articles

The July 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The top analyst upgrades, downgrades and initiations on Monday included Agilent Technologies, Amazon.com, American Water Works, Crocs, Deere, General Electric, Gilead Sciences, Slack and Teva...
The June 28 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were increased.
Here are five more stocks for aggressive accounts looking to get share count leverage on companies that have sizable upside potential.
The June 14 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
The May 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The top analyst upgrades, downgrades and initiations on Tuesday included Agilent Technologies, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook, Luckin Coffee, Lyft, Mylan, Symantec,...
The top analyst upgrades, downgrades and initiations seen on Monday included Alcon, Analog Devices, Big Lots, CACI, CenterPoint Energy, Cree, Lyft, Teva Pharmaceutical and WellCare Health Plans.
The top analyst upgrades, downgrades and initiations seen on Thursday included Apple, Citigroup, Comcast, Cypress Semiconductor, Huya, Six Flags, Tesla, Teva Pharmaceutical, U.S. Steel, Verizon...
The May 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The April 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
The April 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
The March 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with two major movers in the group.
The top analyst upgrades, downgrades and initiations seen on Thursday included Bunge, Cheniere Energy, FedEx, Kinder Morgan, Micron Technology, Monster Beverage, Teva Pharmaceutical and Western...
The March 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with two major movers in the group.